Prevalence and clinical demography of hyperhomocysteinemia in Han Chinese patients with schizophrenia

Eur Arch Psychiatry Clin Neurosci. 2021 Jun;271(4):759-765. doi: 10.1007/s00406-020-01150-x. Epub 2020 Jun 8.

Abstract

Previous studies have shown that high homocysteine worsens the occurrence, symptoms, and prognosis of patients with schizophrenia. The purpose of this study was to evaluate the prevalence, clinical correlation, and demographic characteristics of hyperhomocysteinemia in Han Chinese schizophrenia patients. In this study, we enrolled 330 schizophrenia patients and 190 healthy controls. Positive and Negative Syndrome Scale (PANSS) was used to evaluate the psychiatric symptoms of patients with schizophrenia. The plasma homocysteine level was measured by the enzyme cycle method and the concentration of homocysteine > 15 μmol/L was defined as hyperhomocysteinemia. The prevalence of hyperhomocysteinemia in Han Chinese schizophrenia patients and healthy controls was 55.05% and 26.98%, respectively. Schizophrenia patients with hyperhomocysteinemia had more male proportion, older age, higher smoking rate, lower HDL level, higher PANSS total score, and higher negative factor than those patients without hyperhomocysteinemia. Binary logical regression result showed that gender and age were the independent risk factors of hyperhomocysteinemia. Han Chinese patients with schizophrenia had high prevalence hyperhomocysteinemia than healthy controls, and elderly male patients have a higher risk of hyperhomocysteinemia. This study was registered in the China Clinical Trial Registration Center (chiCTR 1800017044).

Keywords: Homocysteine; PANSS; Prevalence; Psychiatric symptoms; Schizophrenia.

MeSH terms

  • Aged
  • Asian People
  • China / epidemiology
  • Homocysteine
  • Humans
  • Hyperhomocysteinemia* / epidemiology
  • Male
  • Prevalence
  • Risk Factors
  • Schizophrenia* / epidemiology

Substances

  • Homocysteine